500680 Stock Overview
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Pfizer Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,107.35 |
| 52 Week High | ₹4,940.00 |
| 52 Week Low | ₹3,702.15 |
| Beta | 0.32 |
| 1 Month Change | -5.18% |
| 3 Month Change | -3.96% |
| 1 Year Change | 8.86% |
| 3 Year Change | -21.30% |
| 5 Year Change | 31.72% |
| Change since IPO | 195.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500680 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.9% | -2.2% | -2.1% |
| 1Y | 8.9% | 55.3% | 45.3% |
Return vs Industry: 500680 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 500680 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 500680 volatility | |
|---|---|
| 500680 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 500680 has not had significant price volatility in the past 3 months.
Volatility Over Time: 500680's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | 1,702 | Meenakshi Nevatia | www.pfizerltd.co.in |
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names.
Pfizer Limited Fundamentals Summary
| 500680 fundamental statistics | |
|---|---|
| Market cap | ₹188.18b |
| Earnings (TTM) | ₹5.02b |
| Revenue (TTM) | ₹22.19b |
37.5x
P/E Ratio8.5x
P/S RatioIs 500680 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500680 income statement (TTM) | |
|---|---|
| Revenue | ₹22.19b |
| Cost of Revenue | ₹8.23b |
| Gross Profit | ₹13.96b |
| Other Expenses | ₹8.94b |
| Earnings | ₹5.02b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 109.76 |
| Gross Margin | 62.90% |
| Net Profit Margin | 22.63% |
| Debt/Equity Ratio | 3.5% |
How did 500680 perform over the long term?
See historical performance and comparison